Insider Transactions in Q1 2023 at Akero Therapeutics, Inc. (AKRO)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2023
|
William Richard White Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
641
-2.71%
|
$27,563
$43.47 P/Share
|
|
Mar 10
2023
|
Jonathan Young Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
634
-0.34%
|
$27,262
$43.47 P/Share
|
|
Mar 10
2023
|
Catriona Yale Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
701
-0.86%
|
$30,143
$43.46 P/Share
|
|
Mar 10
2023
|
Andrew Cheng President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,706
-0.46%
|
$73,358
$43.47 P/Share
|
|
Mar 10
2023
|
Timothy Rolph Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
603
-0.32%
|
$25,929
$43.47 P/Share
|
|
Mar 01
2023
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-2.14%
|
$1,150,000
$46.44 P/Share
|
|
Mar 01
2023
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+5.94%
|
$0
$0.62 P/Share
|
|
Feb 01
2023
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-2.14%
|
$1,225,000
$49.46 P/Share
|
|
Feb 01
2023
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+5.94%
|
$0
$0.62 P/Share
|
|
Jan 13
2023
|
Catriona Yale Chief Development Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.48%
|
$250,000
$50.55 P/Share
|
|
Jan 03
2023
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-1.08%
|
$1,300,000
$52.54 P/Share
|
|
Jan 03
2023
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+5.94%
|
$0
$0.62 P/Share
|
|
Jan 03
2023
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
8,777
-4.53%
|
$473,958
$54.64 P/Share
|
|
Jan 03
2023
|
Jonathan Young Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,777
+4.34%
|
$0
$0.62 P/Share
|